Tandem Diabetes Care (NASDAQ: TNDM) — Perfil da empresa, notícias e dados financeiros
Tandem Diabetes Care creates innovative insulin pumps and diabetes management technologies for improved care.
Tandem Diabetes Care
Tandem Diabetes Care (NASDAQ:TNDM) specializes in creating innovative solutions for people with diabetes. Its main focus is on developing, manufacturing, and selling insulin pumps and other diabetes management products to improve the lives of those dealing with this chronic condition. By prioritizing user-friendly technology, Tandem aims to enhance the effectiveness of diabetes care and allow users to lead more comfortable and manageable lives. Its projects often involve advancing insulin pump technology, integrating with continuous glucose monitoring systems, and exploring new software solutions to make diabetes management more intuitive. Tandem's objectives revolve around innovation, accessibility, and constant improvement of diabetes care technologies to meet the evolving needs of its customers.
Resumo
Operações
Produtos e/ou serviços de Tandem Diabetes Care
- t:slim X2 insulin pump with Basal-IQ technology offers automatic insulin adjustment to reduce the frequency and duration of hypoglycemia.
- Control-IQ technology enhances the t:slim X2 insulin pump by using CGM data to predict glucose levels and adjust insulin delivery, aiming for tighter glucose control.
- t:connect diabetes management application allows users to easily view their diabetes data and trends, facilitating better disease management strategies.
- t:simulator app provides an interactive way for patients and healthcare providers to learn how to use their insulin pumps and CGM systems.
- TruSteel and VariSoft infusion sets are designed for use with the t:slim X2 insulin pump, offering users choices for comfort and convenience in insulin delivery.
- AutoSoft XC, an infusion set that integrates with their insulin pumps, aims for ease of use and consistent insulin delivery.
equipe executiva do Tandem Diabetes Care
- John F. SheridanPresident, CEO & Director
- Leigh A. VossellerExecutive VP, CFO & Treasurer
- Shannon M. HansenExecutive VP, Chief Legal, Privacy & Compliance Officer and Secretary
- Elizabeth Anne GasserExecutive VP and Chief Strategy & Product Officer
- Jean-Claude E. KyrillosExecutive VP & COO
- Rick A. CarpenterExecutive VP & CTO
- Susan M. MorrisonExecutive VP & Chief Administrative Officer
- Tom FoxExecutive VP & Chief Human Resources Officer
- Jordan PinskerChief Medical Officer
Últimas notícias sobre a Tandem Diabetes Care
Principais indicadores financeiros
Resultados divulgados pela Tandem Diabetes Care, em USD.
- Cap. de mercado
- 1,3 bi
- Receita (TTM)
- 1 bi
- P/L
- —
- LPA (diluído, TTM)
- -0.9
- Dividend yield
- —
- Margem de lucro
- -6.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1 bi | -78,1 mi | -204,7 mi | |
| 940,2 mi | -99,1 mi | -96 mi | |
| 747,7 mi | -233,2 mi | -222,6 mi | |
| 801,2 mi | -92,8 mi | -94,6 mi |